Sources | Names Used |
---|---|
CTRPv2 | BRD-A02303741:navitoclax (2:1 mol/mol) |
PharmacoGx | BRD-A02303741:navitoclax (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | CRMP1 | CTRPv2 | pan-cancer | AAC | 0.27 | 3e-11 |
mRNA | ZFP14 | CTRPv2 | pan-cancer | AAC | 0.24 | 3e-11 |
mRNA | TMSB15A | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
mRNA | ZNF260 | CTRPv2 | pan-cancer | AAC | 0.25 | 4e-11 |
mRNA | MYT1 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
mRNA | GRIK5 | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-11 |
mRNA | LRRC37B | CTRPv2 | pan-cancer | AAC | 0.24 | 6e-11 |
mRNA | SMAD4 | CTRPv2 | pan-cancer | AAC | 0.25 | 7e-11 |
mRNA | ZNF708 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |
mRNA | DOK6 | CTRPv2 | pan-cancer | AAC | 0.24 | 8e-11 |